Compare · CNMD vs DRAD
CNMD vs DRAD
Side-by-side comparison of CONMED Corporation (CNMD) and Digirad Corporation (DRAD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and DRAD operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CNMD carries a market cap of $1.39B.
- CNMD has hit the wire 6 times in the past 4 weeks while DRAD has been quiet.
- CNMD has more recent analyst coverage (16 ratings vs 0 for DRAD).
- Company
- CONMED Corporation
- Digirad Corporation
- Price
- -
- -
- Market cap
- $1.39B
- -
- 1M return
- -5.30%
- -
- 1Y return
- +9.14%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 1987
- 2004
- News (4w)
- 6
- 0
- Recent ratings
- 16
- 0
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Latest CNMD
- Amendment: SEC Form SCHEDULE 13G/A filed by CONMED Corporation
- General Counsel & Corp Sec Foust Hollie K converted options into 4,000 shares and covered exercise/tax liability with 1,124 shares, increasing direct ownership by 100% to 5,762 units (SEC Form 4)
- CONMED Corporation to Participate in the Jefferies Global Healthcare Conference
- SEC Form 10-Q filed by CONMED Corporation
- SEC Form 8-K filed by CONMED Corporation
- CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
- CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
- Director Kelderman Kim converted options into 500 shares (SEC Form 4)
- CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
- SEC Form 10-Q filed by CONMED Corporation
Latest DRAD
- SEC Form 8 filed
- Digirad Corporation to Present at Investor Conferences in November
- Digirad Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2020
- Digirad Corporation to Release Third Quarter 2020 Financial Results on November 13
- Digirad Corporation to Sell DMS Health for $18.75 Million